Omega‐3 vs placeboCognitive function · Apathy in people with mild‐to‐moderate Alzheimer's disease2 findings from 1 reviewOmega‐3 fatty acids for the treatment of dementia 2016 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 566 participantsHighOmega‐3 fatty acids for the treatment of dementia 2016 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 202 participantsHigh